Home
/
NIKA PHARMACEUTICALS, INC
/
Financials
/
Quarterly
NIKA PHARMACEUTICALS, INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that NIKA PHARMACEUTICALS, INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2024
Jun 30, 2024
$156
Nov 1, 2024
Q3
2023
Sep 30, 2023
$0
Oct 31, 2023
Q2
2023
Jun 30, 2023
$0
Aug 21, 2023
Q1
2023
Mar 31, 2023
$0
May 15, 2023
Q3
2022
Sep 30, 2022
$0
Nov 10, 2022
Q2
2022
Jun 30, 2022
$0
Nov 7, 2022
Q1
2022
Mar 31, 2022
$0
May 12, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.0K)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($18.4K)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($12.9K)
May 13, 2025
Q3
2025
Sep 30, 2024
($8.4K)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($22.5K)
Aug 14, 2025
Q3
2024
Jun 30, 2024
($8.4K)
Nov 12, 2024
Q1
2025
Mar 31, 2024
($46.0K)
May 13, 2025
Q3
2023
Sep 30, 2023
($10.1K)
Oct 31, 2023
Q2
2024
Jun 30, 2023
($27.8K)
Nov 1, 2024
Q3
2024
Jun 30, 2023
($10.1K)
Nov 12, 2024
Q2
2023
Mar 31, 2023
($19.6K)
Aug 21, 2023
Q3
2023
Mar 31, 2023
($19.6K)
Oct 31, 2023
Q1
2024
Mar 31, 2023
($19.6K)
May 28, 2024
Q3
2023
Sep 30, 2022
($6.3K)
Oct 31, 2023
Q3
2023
Jun 30, 2022
($3.16M)
Oct 31, 2023
Q2
2023
Jun 30, 2022
($3.16M)
Aug 21, 2023
Q1
2023
Mar 31, 2022
$6.3K
May 15, 2023
Q2
2023
Mar 31, 2022
($6.3K)
Aug 21, 2023
Q3
2023
Mar 31, 2022
($6.3K)
Oct 31, 2023
Q3
2022
Sep 30, 2021
$2.7K
Nov 10, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.0K)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($18.4K)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($12.9K)
May 13, 2025
Q3
2025
Sep 30, 2024
($8.4K)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($22.5K)
Aug 14, 2025
Q3
2024
Jun 30, 2024
($8.4K)
Nov 12, 2024
Q1
2025
Mar 31, 2024
($46.0K)
May 13, 2025
Q3
2023
Sep 30, 2023
($10.1K)
Oct 31, 2023
Q3
2024
Jun 30, 2023
($10.1K)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($27.8K)
Nov 1, 2024
Q1
2024
Mar 31, 2023
($19.6K)
May 28, 2024
Q3
2023
Sep 30, 2022
($6.3K)
Oct 31, 2023
Q2
2023
Jun 30, 2022
($3.16M)
Aug 21, 2023
Q1
2023
Mar 31, 2022
$6.3K
May 15, 2023
Q3
2022
Sep 30, 2021
($2.7K)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($3.0K)
Nov 7, 2022
Q1
2022
Mar 31, 2021
($5.8K)
May 12, 2022
Q3
2021
Sep 30, 2020
($160)
Nov 12, 2021